China has established a network for reporting and monitoring adverse drug reactions (ADR), said a white paper published on Friday by the Information Office of the State Council.
The white paper, titled Status Quo of Drug Supervision in China, said China officially joined the WHO Collaborating Center for International Drug Monitoring in 1998 and promulgated the Measureson Administration of Reporting and Monitoring of Adverse Drug Reactions in 2004, thereby formally adopting a system of reporting and monitoring ADR, the paper said.
By the end of 2002 ADR monitoring institutions at the provincial level and over 200 centers and stations below the provincial level for this purpose had been set up in 31 provinces, autonomous regions and municipalities directly under the central government. By then, a nationwide information network for monitoring ADR had emerged, making it possible for electronic reporting and online real-time reporting, according to the paper.
Since 2000 China has made visible progress in ADR reporting. In2007, some 400 cases of ADR per one million people were reported, a ratio approaching that of the developed countries. This demonstrated the considerable improvement in China's monitoring and early-warning capability regarding ADR, said the paper.
Drug administration departments promptly collect, evaluate and publish information about ADR. By the end of June this year, they had issued 13 bulletins in this respect, involving 44 types of drugs, it said.
Source: Xinhua
|
Comment
Tell A Friend
Print Format
Save Article